Efficacy and Safety Study of IFX-1 in Patients With Moderate to Severe Hidradenitis Suppurativa (HS)

InflaRX Investigational Site, Sofia

InflaRX Investigational Site, Sofia

InflaRX Investigational Site, Copenhagen

InflaRX Investigational Site, Roskilde

InflaRX Investigational Site, Stara Zagora

InflaRX Investigational Site, Athens

InflaRX Investigational Site, Hershey

InflaRX Investigational Site, Chapel Hill

InflaRX Investigational Site, Sandy Springs

InflaRX Investigational Site, Toulouse

InflaRX Investigational Site, Bordeaux

InflaRX Investigational Site, Miami

InflaRX Investigational Site, Fort Myers

InflaRX Investigational Site, Birmingham

InflaRx Investigational Site, Goodlettsville

InflaRX Investigational Site, Nantes

InflaRX Investigational Site, Bochum

InflaRX Investigational Site, Cincinnati

InflaRX Investigational Site, Dearborn

InflaRX Investigational Site, Thessaloniki

InflaRX Investigational Site, Frankfurt am Main

InflaRX Investigational Site, St Louis

InflaRX Investigational Site, St Louis

InflaRX Investigational Site, Darmstadt

InflaRx Investigational Site, Saint Joseph

InflaRX Investigational Site, Columbia

InflaRX Investigational Site, Paris

InflaRX Investigational Site, Antony

InflaRX Investigational Site, St. John's

InflaRX Investigational Site, Peterborough

InflaRX Investigational Site, Richmond Hill

InflaRX Investigational Site, Nice

InflaRX Investigational Site, Dessau

InflaRX Investigational Site, Athens

InflaRX Investigational Site, Rotterdam

InflaRX Investigational Site, Gdansk

InflaRX Investigational Site, Krakow

InflaRX Investigational Site, Kłodzko

InflaRX Investigational Site, Lodz

InflaRX Investigational Site, Wroclaw

InflaRX Investigational Site, Wroclaw